Benzinga | Mar 30, 2021 04:15PM EDT

Crinetics Pharmaceuticals Q4 EPS $(0.66) Misses $(0.58) Estimate

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.58) by 13.79 percent. This is a 10 percent decrease over losses of $(0.60) per share from the same period last year.